drugset / Trial / NCT00034203
Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.
RandomizedDouble-blindTreatment
Summary
The purpose of this study is to determine whether a humanized monoclonal antibody (efalizumab) is safe and effective in the treatment of rheumatoid arthritis.
Timeline
- Start
- 2002-04
- Primary completion
- —
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | efalizumab | Monoclonal antibody | — | — |